Adrian Kinkaid

Adrian Kinkaid is an accomplished executive in the life sciences sector, currently serving as Chief Executive Officer at Fusion Antibodies and as Owner & Managing Director of Scorpio Bioscience, which specializes in consultancy and business support for life science ventures. Kinkaid's extensive experience includes leadership roles at Vortex Biosciences, Lumabs BV, and MIP Diagnostics Ltd, where innovative technologies in diagnostics and molecularly imprinted polymers were developed. Additionally, Kinkaid held various senior positions including Chief Commercial Officer at Promexus and Chief Business Officer at The Aptamer Group. With a strong background in strategic market development and a Doctor of Philosophy in Biochemistry from the University of Southampton, Kinkaid is well-regarded for contributions to corporate and strategic development in the life sciences industry.